ECSP982757A - THENOPYRIMIDINES - Google Patents

THENOPYRIMIDINES

Info

Publication number
ECSP982757A
ECSP982757A ECSP982757A ECSP982757A EC SP982757 A ECSP982757 A EC SP982757A EC SP982757 A ECSP982757 A EC SP982757A EC SP982757 A ECSP982757 A EC SP982757A
Authority
EC
Ecuador
Prior art keywords
treatment
thenopyrimidines
thienopyrimidines
phosphodiesterase
potency
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Maria Christadler
Rochus Jonas
Franz-Werner Kluxen
Pierre Schelling
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP982757 priority Critical patent/ECSP982757A/en
Publication of ECSP982757A publication Critical patent/ECSP982757A/en

Links

Landscapes

  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Las tienopirimidinas de fórmula I: (gráfico), y sus sales aceptables desde el punto de vista fisiológicos en donde R1, R2, R3, R4, X y n tienen los significados indicados en la reinvindicación 1; actúan como inhibidores de la fosfodiesterasa V y pueden ser empleados para el tratamiento de las enfermedades del sistema cardiocirculatorio y para el tratamiento y/o la terapia de los trastornos de la potencia.The thienopyrimidines of formula I: (graph), and their physiologically acceptable salts where R1, R2, R3, R4, X and n have the meanings indicated in claim 1; They act as phosphodiesterase V inhibitors and can be used for the treatment of diseases of the cardiovascular system and for the treatment and / or therapy of disorders of potency.

ECSP982757 1998-11-27 1998-11-27 THENOPYRIMIDINES ECSP982757A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP982757 ECSP982757A (en) 1998-11-27 1998-11-27 THENOPYRIMIDINES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP982757 ECSP982757A (en) 1998-11-27 1998-11-27 THENOPYRIMIDINES

Publications (1)

Publication Number Publication Date
ECSP982757A true ECSP982757A (en) 1999-04-16

Family

ID=42043676

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP982757 ECSP982757A (en) 1998-11-27 1998-11-27 THENOPYRIMIDINES

Country Status (1)

Country Link
EC (1) ECSP982757A (en)

Similar Documents

Publication Publication Date Title
ES2191192T3 (en) TIENOPIRIMIDINAS.
ES2192213T3 (en) ARILALQUIL-DIAZINONAS AS PHOSPHODIESTERASE IV INHIBITORS.
ES2159851T3 (en) AMIDES OF AMINOTIOFENOCARBOXILIC ACIDS AND THEIR EMPLOYMENT AS INHIBITORS OF PHOSPHODIESTEARASA.
AR010348A1 (en) CETOBENZAMIDES, THEIR USE AND PHARMACEUTICAL COMPOSITION THAT CONTAIN THEM
GEP20053511B (en) ) β-Carboline Derivatives Useful as Inhibitors of Phosphodiesterase
EA200300248A1 (en) BICYCLOPIRASOLES, ACTIVE AS KINASE INHIBITORS, METHOD OF THEIR RECEIVING AND INCLUDING THEIR PHARMACEUTICAL COMPOSITIONS
NO20050807L (en) Pharmaceutical compositions including dextromethorphan and quinidine for the treatment of neurological disorders
TR200201505T2 (en) Pirazolopyrimidines as therapeutic agents
MY103352A (en) Piperazinyl-heterocyclic compounds
DK1235826T3 (en) Quinuclidine acrylamides
DK0738270T3 (en) Dihydropyrazolopyrroles
BR9815409A (en) Thienopyrimidines
NO20021448L (en) New thiazolo- (4,5-D) pyrimidine compounds
ES2192839T3 (en) TIMOSINA BETA 4 OXIDADA.
AR024380A1 (en) TIENOPIRIMIDINES
ES2101858T3 (en) GENESERINE DERIVATIVES AS CHOLINESTERASE INHIBITORS.
AR034343A1 (en) PHARMACEUTICAL COMBINATIONS
AR012193A1 (en) NEW THERAPEUTIC COMBINATIONS
AR028705A1 (en) BIS-ARILSULPHONES
AR025569A1 (en) PIRAZOL [4,3-D] PYRIMIDINS
DE60115466D1 (en) ACTIVE PROCESSORS OF IMIDAZOPYRIDINE DERIVATIVES
MY103210A (en) Arylpiperazinyl-alkylene-phenyl-heterocyclic compounds.
ES2038216T3 (en) PROCEDURE FOR THE PREPARATION OF 5- (3-ALKYL-5-T-BUTYL-4-HYDROXY-PHENYL) -2-AMINO-6H-1,3,4-TIADAZINES AND THEIR USE.
ES2124861T3 (en) AMINO ACID DERIVATIVES AND THEIR USE AS ENCEPHALINASE INHIBITORS.
PA8525801A1 (en) PIRAZOL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS TO MODULATE AND / OR INHIBIT THE ACTIVITY OF ERAB / HADH2